HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isolation and characterization of major urinary oligosaccharides excreted by a patient with type 3 GM1 gangliosidosis.

Abstract
Two major oligosaccharides were isolated from the urine of a patient with type 3 GM1 gangliosidosis. From structural studies including compositional sugar analysis, fast-atom bombardment mass spectrometry, direct-inlet chemical ionization mass spectrometry, methylation analysis, chromium trioxide oxidation, and proton magnetic resonance spectroscopy, their structures were deduced to be as follows: [formula: see text] Both oligosaccharides have beta-linked galactose at the non-reducing ends. Oligosaccharide 1 is one of the most common urinary oligosaccharides found in type 1 and type 2 GM1 gangliosidosis. Oligosaccharide 2, lacto-N-difucohexaose II, has not been described in the urine of GM1 gangliosidosis patients. Excretion of oligosaccharide 1 in the type 3 patient was much less than that of a type 2 patient. Thin-layer chromatographic analysis revealed that the excretion of oligosaccharides with higher molecular weight than that of oligosaccharide 1 (octasaccharide) in the type 3 patient was much less than that of a type 2 patient, raising the possibility that the mutant beta-galactosidase of type 3 GM1 gangliosidosis can still act to some extent on higher molecular weight oligosaccharides containing beta-linked galactose at the non-reducing end.
AuthorsS Tsuji, T Ariga, S Ando, Y Tanaka, K Kon, T Yahagi, K Ohta, T Miyatake
JournalJournal of biochemistry (J Biochem) Vol. 109 Issue 5 Pg. 722-7 (May 1991) ISSN: 0021-924X [Print] England
PMID1917896 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Oligosaccharides
Topics
  • Carbohydrate Conformation
  • Carbohydrate Sequence
  • Gangliosidoses (classification, urine)
  • Humans
  • Magnetic Resonance Spectroscopy
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Oligosaccharides (chemistry, urine)
  • Spectrometry, Mass, Fast Atom Bombardment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: